FDA "informal rulemaking" prohibition proposed by House Budget Cmte..
This article was originally published in The Tan Sheet
Executive Summary
FDA "INFORMAL RULEMAKING" PROHIBITION PROPOSED BY HOUSE BUDGET CMTE. in its report on the fiscal year 1996 budget resolution. "The FDA currently makes policy through a variety of improper means," such as "points to consider" documents, draft guidances, speeches and warning letters, according to the report. These activities, which "are difficult to track yet often contain substantive rules," should be eliminated by withholding funding for them through the appropriations process, the committee report states.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning